Clinical pharmaceutical and costs with antimicrobials: a study in an intensive care unit

Abstract

Objective: To evaluate the importance of the clinical pharmacist both in the use of antimicrobials and in reducing the cost of these drugs. Method: The study, characterized as descriptive, with a quantitative approach, was carried out from October to December 2016 in an Intensive Care Unit of a public hospital in the city of Caruaru-PE. Data collection occurred through documentary analysis using the MV200 standard operating system as a tool. Results: There was a greater use of piperacillin + tazobactam and meropenem, both antibiotics with a broad spectrum of action, evidencing the choice of therapies by the patients. hospital protocols with this characteristic. However, there is no significant reduction in costs due to the high prevalence of antimicrobials still prevalent among ICU patients. Conclusion: In view of the results, it appears that the action of a clinical pharmacist in the Intensive Care Unit would help with greater control of these prescriptions, avoiding drug interactions and meeting the needs of each patient.